recomLine HCV
Line immunoassay for the detection of IgG antibodies
against hepatitis C virus (HCV) in human serum or plasma
against hepatitis C virus (HCV) in human serum or plasma
Mikrogen recomLine HCV IgG Test is a serological, quantitative in vitro line immunoassay based on recombinantly produced HCV antigens from the regions Core, NS3, NS4 and NS5. It provides simple and reliable confirmation of HCV screening results.
recomLine HCV IgG
| Product | Size | Article no. | |
|---|---|---|---|
|
Reagents for 20 determinations
|
Article no.: 4372 | Request |
Downloads
Advantages
- Very high seroconversion sensitivity allows early diagnosis
- 100% sensitivity in confirmed anti-HCV samples
- High specificity in blood donors and clinical samples
- No cross-reactions with samples from patients with other viral hepatitis infections
- Antibody detection of all major HCV genotypes (1 - 6)
- Easy and clear interpretation due to easy-to-read banding
- Partial and full automation, software-based evaluation (recomScan) and integration with laboratory information system possible
- Highest sensitivity and specificity through the use of 6 recombinant, serologically relevant HCV antigens:
| Region | Antigen |
| Core 1 | Capsid antigen - structural proteins of the virus |
| Core 2 | Capsid antigen - structural proteins of the virus |
| Helicase | Non-structural protein - subunit of the NS3 protein with helicase activity |
| NS3 | Non-structural protein with protease and helicase activity |
| NS4 | Non-structural protein |
| NS5 | Non-structural protein |
Safe and reliable
Validity check by integrated, strip-specific cutoff and antibody class controls
Flexible and compatible
Combination of all microgen line immunoassays possible - uniform processing and interchangeable reagents
High Standard
CE mark: The recomLine HCV test meets the high standard of the EC Directive 98/79/EC for in vitro diagnostic medical devices.